Contract with Customer, Liability, Current of KalVista Pharmaceuticals, Inc. from 30 Apr 2018 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: KalVista Pharmaceuticals, Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 30 Apr 2018 to 30 Sep 2025.
KalVista Pharmaceuticals, Inc. Contract with Customer, Liability, Current for the quarter ending 30 Sep 2025 was $11,512,000.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$11,512,000			30 Sep 2025	10-Q	10 Nov 2025	2025	Q3
Q2 2025	$11,413,000			31 Jul 2025	10-Q	11 Sep 2025	2026	Q1
Q1 2025	$11,000,000			30 Apr 2025	10-Q	11 Sep 2025	2026	Q1
Q4 2019	$1,343,000	-$10,968,000	-89%	31 Jan 2020	10-Q	10 Mar 2020	2020	Q3
Q3 2019	$2,601,000	-$12,168,000	-82%	31 Oct 2019	10-Q	03 Dec 2019	2020	Q2
Q2 2019	$6,023,000	-$11,184,000	-65%	31 Jul 2019	10-Q	09 Sep 2019	2020	Q1
Q1 2019	$9,545,000	-$8,930,000	-48%	30 Apr 2019	10-K	01 Jul 2020	2020	FY
Q4 2018	$12,311,000			31 Jan 2019	10-Q	14 Mar 2019	2019	Q3
Q3 2018	$14,769,000			31 Oct 2018	10-Q	14 Dec 2018	2019	Q2
Q2 2018	$17,207,000			31 Jul 2018	10-Q	14 Sep 2018	2019	Q1
Q1 2018	$18,475,000			30 Apr 2018	10-K	16 Jul 2019	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.